共 50 条
- [41] Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trialFRONTIERS IN PHARMACOLOGY, 2023, 14Cheng, JunlinLong, JunZhang, JingjingHan, LeHu, YunfangLiu, JianghuiQiu, RunzeZhu, ZhibinFan, Hongwei
- [42] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I StudyAdvances in Therapy, 2023, 40 : 3186 - 3198Qian ZhaoHongzhong LiuZhenlei WangTeng WangCheng CuiHuanhuan WangLili LiWen ZhongJi JiangKai DongShuai ChenChunyan JinPei Hu
- [43] A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult SubjectsDRUG RESEARCH, 2023, 73 (02) : 95 - 104Brager, JennaChapman, ChrisDunn, LeonardKaplin, Adam
- [44] Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult SubjectsJOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (06): : 770 - 776Guptill, Jeffrey T.Raja, Shruti M.Boakye-Agyeman, FelixNoveck, RobertRamey, SarahTu, Tian MingLaskowitz, Daniel T.
- [45] Safety, pharmacokinetics and biologic volunteers: Results of a placebo controlled randomized double-blind phase 1 study.BLOOD, 1997, 90 (10) : 761 - 761Serdar, CMHeard, RPrathikanti, RLau, DDanilenko, DHunt, TLacey, D
- [46] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Small Molecule GLP-1 Receptor Agonist (HRS-7535) in Healthy Subjects -A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose StudyDIABETES, 2023, 72Wu, JingyingHu, WeiDu, YijunZhang, QianZhou, RenpengZhang, QinQin, HuilingYe, ZiXu, YimeiFeng, ShengShu, ChangShen, YuFan, Yang
- [47] Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers - A randomized, placebo-controlled, double-blind, multi-dose studyTHROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 802 - 807Visich, JEZuckerman, LAButine, MDGunewardena, KAWild, RMorton, KMReynolds, TC
- [48] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled StudyADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643Li, YiToyama, KaoruNakatsu, TakafumiIshizuka, HitoshiWu, HailanCao, GuoyingYu, JichengWang, YuLiu, XiaofenGuo, BeiningWu, JufangYu, PeiminHong, ZhenZhang, JingWu, Xiaojie
- [49] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled StudyAdvances in Therapy, 2023, 40 (4) : 1628 - 1643Yi LiKaoru ToyamaTakafumi NakatsuHitoshi IshizukaHailan WuGuoying CaoJicheng YuYu WangXiaofen LiuBeining GuoJufang WuPeimin YuZhen HongJing ZhangXiaojie Wu
- [50] PHARMACOKINETICS AND PHARMACODYNAMICS OF RANITIDINE AND FAMOTIDINE IN HEALTHY ELDERLY SUBJECTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISONPHARMACOTHERAPY, 1993, 13 (01): : 3 - 9BISSON, CSTLAURENT, MMICHAUD, JTLEBEL, M